Feb. 21 – FDA Approves New Treatment for Fungal Infections
The Food and Drug Administration approved Eraxis™ (anidulafungin) to treat certain infections caused by Candida, a yeast-like fungus that can cause serious infections in hospitalized patients or patients with compromised immune systems. “This product offers a new alternative therapy for several types of infections associated with Candida”, said Dr. Steven Galson, director of the FDA’s […]